deaths from tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial Effects of Tirzepatide on the

Consuming adequate calcium through diet and supplementation is associated with higher bone-mineral density (Napoli 2007)

A 28.7% average weight loss at 68 weeks coupled with transformative improvements in knee osteoarthritis pain, cardiovascular risk markers, and metabolic health represents a genuine advance in obesity treatment

Activation of GLP-1 Rs triggers glucose-dependent insulin secretion, suppression of glucagon release, delayed gastric emptying, and promotion of satiety (Kim and Egan, 2008

Klinic Accepts Insurance and Handles Prior Authorization By turning to Klinic, Sterling, Colorado residents benefit from comprehensive support when it comes to weight loss medications covered by insurance